CC2019: Blood Product Transfusion: The Sum of the Parts Is Greater Than the Whole - or Is It? (T)
This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Trauma. Learn more about ACS Accreditation/Verification Requirements.
Transfusion strategies for hemorrhagic shock have changed dramatically over the past decade. Ideal transfusion ratios of packed red blood cells, fresh frozen plasma, and platelets are now appreciated based upon research from military and civilian trauma. Evolving research on transfusion based upon functional assays of clotting (viscoelastography) are guiding blood component therapy. Additional research suggests the benefit of whole blood transfusion instead of component therapy. Furthermore, the benefit of prehospital fresh frozen plasma in trauma to reduce mortality is only recently recognized. The purpose of this symposia is to highlight recent and ongoing research on transfusion medicine that is guiding clinical transfusion for hemorrhagic shock.
Moderator: Karen J. Brasel, MD, FACS, Portland, OR
Co-Moderator: Matthew D. Neal, MD, FACS, Pittsburgh, PA
Whole Blood Transfusion
Bryan A. Cotton, MD, MPH, FACS, Houston, TX
Prehospital Blood Product Transfusion in the Military
Stacy A. Shackelford, MD, FACS, Fort Sam Houston, TX
Blood Product Resuscitation in Pediatric Patients
Barbara A. Gaines, MD, FACS, Pittsburgh, PA
Prehospital Plasma Resuscitation
Jason L. Sperry, MD, MPH, FACS, Pittsburgh, PA
Sponsored by the Committee on Trauma and the Surgical Research Committee
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
For questions about the course, please contact email@example.com.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures).
Faculty and Disclosures
Barbara A. Gaines MD, FACS - Nothing to Disclose
Bryan A. Cotton, MD, MPH, FACS - Haemonetics Corporation (Braintree, MA): Consulting Fee: Scientific Advisory Board and Consultant
Jason L. Sperry MD, MPH, FACS - Nothing to Disclose
Karen J. Brasel MD, FACS - Nothing to Disclose
Matthew D. Neal, MD, FACS - CSL Behring: Honorarium: Advisory Board; Accriva Diagnostics: Research support: Investigator; Haemonetics: Research support: Investigator; Janssen Pharmaceuticals: Research support: Investigator
Stacy A. Shackelford MD, FACS - Nothing to Disclose
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - Nothing to Disclosure
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - Nothing to Disclosure
David C. Borgstrom, MD, FACS, Morgantown, WV - Nothing to Disclosure
Daniel L. Dent, MD, FACS, San Antonio, TX - Nothing to Disclosure
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Cynthia D. Downard, MD, FACS, Louisville, KY - Nothing to Disclosure
Audra A. Duncan, MD, FACS, London, ON - Nothing to Disclosure
Mariam F. Eskander, MD, Boston, MA - Nothing to Disclosure
Paula Ferrada, MD, FACS, Richmond, VA - Nothing to Disclosure
Neil H. Hyman, MD, FACS, Chicago, IL - Nothing to Disclosure
Martin S. Karpeh, Jr., MD, FACS, New York, NY - Nothing to Disclosure
Dennis H. Kraus, MD, FACS, New York, NY - Nothing to Disclosure
Kenneth W. Sharp, MD, FACS, Nashville, TN - Nothing to Disclosure
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - Nothing to Disclosure
Edith Tzeng, MD, FACS, Pittsburgh, PA - Nothing to Disclosure
Barbara Lee Bass, MD, FACS, FRCSEng(Hon), FRCSI(Hon), FCOSECSA(Hon), Houston, TX - Nothing to Disclosure
Quan-Yang Duh, MD, FACS, San Francisco, CA - Nothing to Disclosure
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - Nothing to Disclosure
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - Nothing to Disclosure
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Certificate of Completion
- 1.50 Self Assessment Credit